One-stage endometrial ablation: results in 200 cases
article
OA: closed
CC0
⤵ 4 in-corpus citations
AI-generated summary
This paper reports on the outcomes of one-stage endometrial ablation procedures performed in 200 patients.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
Until now, endometrial ablation (EA) included at least three steps: (1) D & C or hysteroscopic endometrial sampling; (2) Danazol treatment; and (3) the ablation. We have found that step (2) can be omitted if EA is performed between days 2-7 of the menses. This permits to combine steps (1) and (3) into a single stage EA which is a very simple, feasible, efficient and safe treatment for dysfunctional bleeding. Simple: because one stage without hormonal pretreatment, causing almost no pain and only a minimal time off work. It is not more of a burden than D & C with hysteroscopy. General anaesthesia is used in 94% of our patients. Feasible: in one case only (GOPO) the cervix could not be dilated wide enough. Efficient: good results in 97.5%: 67% complete amenorrhea, 24% slight menstrual spotting for a maximum of 2 days, 6% reduced flow and 0.5% normal flow. There are 2.5% failures. When menorrhagia is accompanied by otherwise unexplained dysmenorrhea, the pain is completely cured in 73%, unchanged in 7% and greatly improved in 20%. Safe: mild complications in 2.5% only. We have also combined the two main methods of endometrial destruction: electrocoagulation and Nd/Yag laser. Our 97.5% good results, however, is not a definite proof that a combination of these two techniques is better than either technique alone.
My notes (saved in your browser only)
Citation neighborhood (sparse)
Too few in-corpus citations on either side for a chart; here are the lists.
Cites (3)
- Complications of abdominal and vaginal hysterectomy among women of reproductive age in the United States 1982
- Electrocoagulation of the endometrium with the ball-end resectoscope. 1989
- Basic and advanced laser surgery in gynecology 1985
Cited by (4)
- A pragmatic randomised comparison of transcervical resection of the endometrium with endometrial laser ablation for the treatment of menorrhagia 1997
- Hormonal inhibition of endometrium for transcervical endometrial ablation-a prospective study with a 2-year follow-up 1997
- Dysfunctional uterine bleeding: advances in diagnosis and treatment 2001
- A national survey of the complications of destruction for menstrual disorders: the MISTLETOE study 1998
References (20)
- Basic and advanced laser surgery in gynecology via openalex
- Complications of abdominal and vaginal hysterectomy among women of reproductive age in the United States via openalex
- Electrocoagulation of the endometrium with the ball-end resectoscope. via openalex
- doi:10.1097/00006250-199011000-00032 via openalex
- doi:10.1007/978-1-4684-0330-5_19 via openalex
- doi:10.1007/978-1-4612-3728-0 via openalex
- W2412747916 via openalex
- W2412862318 via openalex
- W2422822557 via openalex
- W2433041954 via openalex
- W6607304629 via openalex
- W6715035132 via openalex
- W6830596110 via openalex
- doi:10.1089/gyn.1986.2.203 via openalex
- doi:10.1002/lsm.1900090607 via openalex
- doi:10.1136/bmj.298.6682.1209 via openalex
- doi:10.1016/s0002-9378(85)80067-3 via openalex
- doi:10.1016/0140-6736(91)91718-a via openalex
- doi:10.1016/0002-9378(76)90471-3 via openalex
- doi:10.1016/s0889-8545(21)00106-6 via openalex
Cited by (4)
- Dysfunctional uterine bleeding: advances in diagnosis and treatment 2001
- A national survey of the complications of destruction for menstrual disorders: the MISTLETOE study 1998
- Hormonal inhibition of endometrium for transcervical endometrial ablation-a prospective study with a 2-year follow-up 1997
- A pragmatic randomised comparison of transcervical resection of the endometrium with endometrial laser ablation for the treatment of menorrhagia 1997
Source provenance
- openalex
- last seen: 2026-05-11T06:18:49.075943+00:00
- unpaywall
- last seen: 2026-08-09T06:42:26.407065+00:00
License: CC0
· commercial use OK